Related Experiment Videos
Cell proliferation in lung fibrosis-associated hyperplastic lesions
A Nishikawa1, F Furukawa, T Imazawa
1Division of Pathology, National Institute of Health Sciences, Tokyo, Japan.
Human & Experimental Toxicology
|September 1, 1995
Summary
Bleomycin (BLM) or radiation can cause lung fibrosis with atypical epithelial cell growth. These lung lesions show high proliferative activity, indicating potential for further development.
Area of Science:
- Pulmonary Medicine
- Oncology
- Cell Biology
Background:
- Lung fibrosis can arise from treatments like bleomycin (BLM) or radiation therapy.
- Investigating epithelial cell proliferation is crucial for understanding fibrotic lung disease progression.
Observation:
- A study compared lung tissue from BLM-treated, irradiated, and control individuals, alongside lung cancer cases.
- Histochemical analysis of argyrophil nucleolar organiser regions (AgNORs) and proliferating cell nuclear antigen (PCNA) was performed.
Findings:
- Atypical bronchioloalveolar hyperplasia and squamous metaplasia were more prominent in BLM-treated cases.
- Both BLM and irradiation induced significantly higher AgNOR numbers in hyperplastic lesions compared to controls.
- PCNA-labelling indices corroborated AgNOR findings, indicating high proliferative activity.
Implications:
- Atypical hyperplastic lesions in the bronchioloalveoli during BLM or irradiation-induced fibrosis are highly proliferative.
- These findings suggest a potential for these lesions to progress, warranting further investigation.
- Understanding the proliferative nature of these lesions is key for managing treatment-related lung injury.